Anti-heart autoantibodies in familial dilated cardiomyopathy
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Familial aggregation is a feature of myocarditis and dilated cardiomyopathy (DCM). Myocarditis, a clinically polymorphic inflammatory disease of the myocardium, is diagnosed by endomyocardial biopsy (EMB) and may lead to DCM. Mutations in several genes encoding myocyte structural proteins are known monogenic DCM causes, but because of high etiologic and genetic heterogeneity, the gene defects identified so far account for a minority of cases. In the last decade, it has been discovered that autoimmunity plays a pivotal role in myocarditis and DCM that are thought to represent different stages of an organ-specific autoimmune disease in genetically predisposed individuals. None of the available genetic studies in familial DCM has taken into account the autoimmune phenotype markers in the characterization of index patients and relatives, thus it is not known whether or not the described gene defects are involved in the autoimmune form of the disease. In animal models autoimmune myocarditis/DCM can be induced by viral infection, immunization with heart-specific autoantigens, or develop spontaneously in genetically predisposed strains. It may be cell or antibody-mediated; susceptibility is based upon multiple MHC and non-MHC genes. In patients, the diagnosis of autoimmune myocarditis/DCM requires exclusion of viral genome on EMB and detection of serum heart-reactive autoantibodies. They are found in index patients and relatives from about 60% of both familial and non-familial pedigrees and predict DCM development among healthy relatives. Some antibodies have functional effects on cardiac myocytes in vitro, in animal models and possibly in a DCM subset without inflammation, responsive to extracorporeal immunoadsorption. Cardiac-specific autoantibodies, which are shown to be disease-specific for myocarditis/DCM, can be used as biomarkers for identifying patients in whom, in the absence of active infection of the myocardium, immunosuppression and/or immunomodulation may be beneficial and their relatives at risk. Future studies should clarify genetic basis of human autoimmune myocarditis/DCM as well as genotype/immune phenotype correlations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1996) · Circulation · doi:10.1161/01.cir.93.5.841 · Cited by 3,458 · cited 2×
“[5] Richardson P, McKenna WJ, Bristow M, et al.”
BackgroundMethodAutoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient Mice
Nishimura, H., Okazaki, T., Tanaka, Y., Nakatani, K., Hara, M., Matsumori, A., Sasayama, S., Mizoguchi, A., Hiai, H., Minato, N., et al. (2001) · Science · doi:10.1126/science.291.5502.319 · Cited by 1,868
Risk Alleles for Multiple Sclerosis Identified by a Genomewide Study
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa073493 · Cited by 1,746
Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes
Finland, G. O. T. 1. D. I., Todd, J. A., the Wellcome Trust Case Control Consortium, Walker, N. M., Cooper, J. D., Smyth, D. J., Downes, K., Plagnol, V., Bailey, R., Nejentsev, S., et al. (2007) · Nature Genetics · doi:10.1038/ng2068 · Cited by 1,456 · cited 1×
“[20] Todd JA, Walker NM, Cooper JD, et al.”
BackgroundArrhythmogenic Right Ventricular Cardiomyopathy: Dysplasia, Dystrophy, or Myocarditis?
Basso, C., Thiene, G., Corrado, D., Angelini, A., Nava, A., & Valente, M. (1996) · Circulation · doi:10.1161/01.cir.94.5.983 · Cited by 890
Okazaki, T., Tanaka, Y., Nishio, R., Mitsuiye, T., Mizoguchi, A., Wang, J., Ishida, M., Hiai, H., Matsumori, A., Minato, N., et al. (2003) · Nature Medicine · doi:10.1038/nm955 · Cited by 689
Frustaci, A., Chimenti, C., Calabrese, F., Pieroni, M., Thiene, G., & Maseri, A. (2003) · Circulation · doi:10.1161/01.cir.0000048147.15962.31 · Cited by 462 · cited 2×
“In fact, in keeping with response to immunosuppression being a major feature of autoimmune disease [16], studies suggest its benefit in immune-mediated myocarditis/DCM [34,94].”
BackgroundEriksson, U., Ricci, R., Hunziker, L., Kurrer, M. O., Oudit, G. Y., Watts, T. H., Sonderegger, I., Bachmaier, K., Kopf, M., & Penninger, J. M. (2003) · Nature Medicine · doi:10.1038/nm960 · Cited by 405 · cited 1×
“[4] Eriksson U, Ricci R, Hunziker L, et al.”
BackgroundJahns, R., Boivin, V., Siegmund, C., Inselmann, G., Lohse, M. J., & Boege, F. (1999) · Circulation · doi:10.1161/01.cir.99.5.649 · Cited by 262
Lauer, B., Schannwell, M., Kühl, U., Strauer, B.-E., & Schultheiss, H.-P. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00485-4 · Cited by 197 · cited 5×
“[49] Lauer B, Schannwell M, Kuhl U, et al.”
BackgroundResultInfluential
Cited by
Inflammatory Cardiomyopathic Syndromes
Trachtenberg, B. H., & Hare, J. M. (2017) · Circulation Research · doi:10.1161/circresaha.117.310221 · Cited by 289
Circulating c-Met–Expressing Memory T Cells Define Cardiac Autoimmunity
Fanti, S., Stephenson, E., Rocha-Vieira, E., Protonotarios, A., Kanoni, S., Shahaj, E., Longhi, M. P., Vyas, V. S., Dyer, C., Pontarini, E., et al. (2022) · Circulation · doi:10.1161/circulationaha.121.055610 · Cited by 44
“32,33,37,38 In this imprecise context, we sought to investigate whether phenotypic or functional differences in circulating c-Met + T cells could provide evidence of an evolving chronic autoimmune response in iDCM.”
Uccello, G., Bonacchi, G., Rossi, V. A., Montrasio, G., & Beltrami, M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm13010150 · Cited by 33
“CMR provides information on differential diagnosis (arrhythmogenic right ventricular cardiomyopathy, idiopathic DCM, sarcoidosis, hypertrophic of infiltrative cardiomyopathy, and ischemic or non-ischemic patterns).”
Background
Metadata
- Authors
- Caforio, A. L. P., Vinci, A., & Iliceto, S.
- Venue
- Autoimmunity
- Publisher
- Informa UK Limited
- Published
- 2008-01
- Volume
- 41
- Issue
- 6
- Pages
- 462-469
- ISSN
- 0891-6934 (ISSN-L)
- 1607-842X
- OpenAlex
- W2130782486
- Cited by
- 43
- References
- 17
- FWCI
- 1.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Anti-heart autoantibodies in familial dilated cardiomyopathy. https://app.cochat.ai/papers/10.1080/08916930802031546
- The paper
- Caforio, A. L. P., Vinci, A., & Iliceto, S. (2008). Anti-heart autoantibodies in familial dilated cardiomyopathy. Autoimmunity. https://doi.org/10.1080/08916930802031546
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.